Seattle Children's Announces New Leadership with Dr. Longhurst
In a momentous transition, Seattle Children's has named Dr. Christopher Longhurst as its new chief executive officer, with the appointment set to take effect in early 2026. This decision comes after a thorough search process conducted by the hospital's Board of Trustees, reflecting a commitment to finding a leader who embodies both clinical excellence and innovative healthcare strategies.
Board's Perspective on Dr. Longhurst's Appointment
"Choosing a CEO is one of the board's most important responsibilities. Dr. Longhurst's unique ability to merge clinical operations, research and digital strategy, while enhancing patient safety and quality makes him the right leader to guide Seattle Children's into the future," remarked Kurt Shintaffer, chair of the Board. His confidence in Dr. Longhurst stems from a belief that his potent combination of visionary leadership and extensive clinical knowledge will bolster Seattle Children's mission to serve families effectively.
Dr. Longhurst's Professional Background
Dr. Longhurst comes to Seattle Children's after establishing himself as a prominent figure in the healthcare landscape. Currently serving as the chief clinical and innovation officer at UC San Diego Health, he brings a wealth of experience from over ten years within that environment, complemented by his previous commitment to Lucile Packard Children's Hospital Stanford. A dedicated pediatrician and a West Coast native, his background is reflective of a passion for children's healthcare.
A Strong Vision for Seattle Children's
Upon accepting the role, Dr. Longhurst expressed his enthusiasm: "Seattle Children's has an extraordinary legacy of care, research, and advocacy for kids and families, and it is a true honor to lead this world-class team as we continue to implement our essential mission." His recognition of the crucial role children's hospitals play in shaping future health demonstrates his dedication to continuing the organization’s long-standing commitment to excellence.
Continuing a Legacy of Impact
Dr. Longhurst is set to succeed Dr. Jeff Sperring, who has led Seattle Children's with unwavering commitment for a decade. Dr. Sperring stated, "It's an exciting day for Seattle Children's as we announce the next leader of our beloved institution. We are incredibly fortunate to add Chris' deep commitment to our mission and his experience as a leader in delivering exceptional outcomes through clinical excellence, scientific discovery, and innovation." This transition underscores the alignment within the hospital as they embark on this exciting new chapter in their journey.
Innovative Contributions to Pediatric Care
Throughout his career, Dr. Longhurst has made significant strides in health innovation. He is the founder and executive director of the Joan & Irwin Jacobs Center for Health Innovation at UC San Diego Health, where he was instrumental in securing funding for transformative projects, including an advanced mission control center that leverages artificial intelligence to enhance patient care. His notable work in health informatics and safety will be critical as Seattle Children's aims to lead in pediatric healthcare.
Additionally, Dr. Longhurst has an academic role at UC San Diego School of Medicine, overseeing education and research alongside being a faculty member in both Biomedical Informatics and Pediatrics. His published research in esteemed medical journals showcases his commitment to advancing pediatric care quality, further establishing him as a national leader in the field.
About Seattle Children's
Seattle Children's is dedicated to providing hope, care, and cures to ensure that every child can lead a healthy and fulfilling life. Partnering with its Hospital, Research Institute, and Foundation, Seattle Children's focuses on excellent patient care, groundbreaking research, and advocacy, all in support of its mission.
Recognized among the best children's hospitals nationwide, Seattle Children's serves as the primary academic medical center dedicated to pediatrics across a vast region. As one of the top pediatric research centers in the country, its innovative programs are well-regarded in various specialties including neurosciences, immunology, and infectious diseases, underpinning its commitment to excellence.
Frequently Asked Questions
Who is Dr. Christopher Longhurst?
Dr. Christopher Longhurst is a pediatrician and the newly appointed CEO of Seattle Children's, set to start in January 2026.
What experience does Dr. Longhurst have?
He previously served as the chief clinical and innovation officer at UC San Diego Health and has significant experience in pediatric care and health innovation.
Why is Dr. Longhurst's appointment significant?
His appointment is viewed as a pivotal moment for Seattle Children's, aligning leadership with a commitment to advancing pediatric healthcare through innovation.
What will Dr. Longhurst focus on at Seattle Children's?
He aims to enhance patient care, integrate research with clinical practice, and uphold the institution's mission of advocacy for children and families.
How does Seattle Children's contribute to the community?
Seattle Children's is dedicated to providing comprehensive care, conducting research that leads to new treatments, and advocating for children's health across its extensive service area.
